Illustrative stock photograph of beverage cans; these are not identified as THC products. Photo by YesMore Content on Unsplash.

New Jersey lawmakers are pursuing two changes that could reshape the cannabis retail landscape: more time for certain hemp beverage sales and tougher penalties for businesses selling cannabis without a license.

The Senate Judiciary Committee advanced both measures on October 15. As of October 22, the Legislature lists S4635, the hemp measure, at second reading in the Senate. The enforcement proposal, S4287, has been referred to the Senate Budget and Appropriations Committee. Neither listing shows an enacted law.

A deadline that would follow federal law

S4635 would align state restrictions on hemp products and intoxicating hemp beverages with the effective dates of federal changes. Its Assembly counterpart is A5604.

An October 15 Assembly committee statement explains that a September federal funding measure partially delayed the relevant changes until December 11, 2026. The proposal is designed to accommodate further federal timing changes, rather than simply replace one fixed date with another.

That distinction matters for shops planning inventory. New Jersey’s existing Chapter 13 law allows specified alcohol and cannabis license holders to sell intoxicating hemp beverages until November 13. A bill moving through committee does not itself change that deadline.

A separate push on unlicensed sales

In October 19 reporting for Cannabis Business Times, Tony Lange explains that S4287 would make certain unlicensed commercial cannabis sales a third-degree crime. Proposed fines range from $10,000 to $50,000 for covered individuals and $100,000 to $250,000 for covered business entities.

The measures address different questions: how long qualifying hemp products can remain in existing sales channels, and what happens when businesses sell outside the licensing system. For shoppers, the next meaningful development is passage and enactment—not simply a committee vote. For now, these are proposals to watch, not new permissions for retailers.

Related reading: Delaware’s approach to THC beverage rules.

SNDL has increased its indirect interest in U.S. cannabis operator Parallel, adding to the Canadian company’s exposure to the American medical market. In an October 15 corporate update, SNDL put that interest at approximately 92%, up from roughly 67%.

The change followed a recently completed rights offering by Parallel, which includes Surterra Holdings and certain affiliates. SNDL says the transaction provides liquidity for Parallel’s near-term plans.

There is also a Florida facility project to watch. According to SNDL, SunStream is funding the acquisition and buildout of a cultivation and processing operation in Gainesville intended to supply Parallel’s retail network in the state. The announcement gives no opening date.

The larger stake does not mean a full operational integration has been completed. SNDL describes potential future integration as subject to legal, regulatory, accounting and Nasdaq requirements.

For readers following who stands behind dispensary shelves, this is an ownership and supply-chain development. It does not yet establish a change to the products available in stores.

Image: AI-generated editorial illustration; not a depiction of a SNDL or Parallel facility.

A majority of Massachusetts voters surveyed by UMass Amherst and WCVB say they oppose Question 8, the ballot measure that would repeal the state’s regulated adult-use cannabis sales system.

The poll released October 19 found 61% would probably or definitely vote no, compared with 31% who would probably or definitely vote yes. Another 5% were undecided, while 3% said they did not understand the question.

That combined opposition figure is worth distinguishing from the 47% who said they would definitely vote no. The survey records both the direction and strength of respondents’ intentions.

YouGov conducted the fieldwork October 5–12. The final matched sample included 800 registered voters, and the poll reports a margin of error of 4.2 percentage points. These are survey responses ahead of the November 3 election, not a result or a guarantee of turnout.

According to the state’s official voter guide, a yes vote would repeal the laws governing adult-use retail sales and change possession penalties. The proposed law would retain a medical cannabis market and take effect January 1, 2028. A no vote would leave the law unchanged.

The distinction for cannabis consumers is substantial: the proposal concerns access through the adult-use retail system, alongside changes to possession rules. The poll suggests repeal faces opposition, but voters will decide its fate.

Image: AI-generated conceptual editorial illustration about cannabis ballot polling.